References

1. Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, et al. (1995) A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 25: 1345-1350 [CrossRef] [Google Scholar] [PubMed]
2. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869 [CrossRef] [Google Scholar] [PubMed]
3. Guo ZX, Qiu MC (2003) [Losartan downregulates the expression of transforming growth factor beta type I and type II receptors in kidney of diabetic rat]. Zhonghua Nei Ke Za Zhi 42: 403-408 [Google Scholar] [PubMed]
4. Kopple JD, Ding H, Letoha A, Ivanyi B, Qing DP (2002) L-carnitine ameliorates gentamicin-induced renal injury in rats. Nephrol Dial Transplant. 17: 2122-2131 [CrossRef] [Google Scholar] [PubMed]
5. Sakthi SP, Vadivu R, Jayshree N (2010) Hypolipidaemic and Renoprotective study on the Ethanolic & Aqueous extracts of leaves of Ravenala madagascariensis Sonn., on alloxan induced diabetic rats. Int J Pharm Sci 2: 44-50 [View]
6. Takashi A, Hiromu T, Yuka I, Hiroko M (2002) Antibacterial activity of Extracts prepared from tropical and subtropical plants on methicillin–resistant Staphylococcus Aureus. J Health Science 48: 273-276 [CrossRef] [Google Scholar]
7. Cau J, Favreau F, Tillement JP, Lerman LO, Hauet T (2008) Trimetazidine reduces early and long-term effects of experimental renal warm ischemia: a dose effect study. J Vasc Surg 47: 852-860 [CrossRef] [Google Scholar] [PubMed]
8. Fawcett jK, Scott JE (1960) A rapid and precise method for the determination of urea. J Clin Path 13: 156-159 [CrossRef] [Google Scholar] [PubMed]
9. Bartels H, Bohmer M (1971) [Micro-determination of creatinine]. Clin Chim Acta 32: 81-85 [CrossRef] [PubMed]
10. Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, et al. (2000) Differential effects of bosentan and valsartan with respect to progressive diabetic renal pathology in the transgenic (mRen- 2)27-rat model. Kidney Int 57: 1882–1894
11. Suzuki S, Takamura S, Yoshida J, Shinzawa Y, Niwa O, et al. (1995) Comparison of gentamicin nephrotoxicity between rats and mice. Camp Biochem Physiol Pharmacol Toxical Endocrinal 112: 15-28 [CrossRef] [Google Scholar] [PubMed]
12. Abdel-Raheem IT, EL-Sherbiny G, Taye A (2010) Green tea ameliorates renal oxidative damage induced by gentamicin in rats. Pak J Pharm Sci 23: 21-28 [Google Scholar] [PubMed]
13. Naidu MU, Shifow AA, Kumar KV, Ratnakar KS (2000) Ginkgo biloba extract ameliorates gentamicin-induced nephrotoxicity in rats. Phytomedicine. 7: 191- 197 [CrossRef] [Google Scholar] [PubMed]
14. Sandhya P, Varalakshmi P (1997) Effect of lipoic acid administration on gentamicin-induced lipid peroxidation in rats. J Appl Toxicol 17: 405-408 [CrossRef] [Google Scholar] [PubMed]
15. Heeba GH (2011) Angiotensin II receptor blocker, losartan, ameliorates gentamicin-induced oxidative stress and nephrotoxicity in rats. Pharmacology 87: 232-240 [CrossRef] [Google Scholar] [PubMed]
16. Hall A, Karplus PA, Poole LB (2009) Typical 2-Cys peroxiredoxins--structures, mechanisms and functions. FEBS J 276: 2469-2477 [CrossRef] [Google Scholar] [PubMed]
17. Herrera M, Silva GB, Garvin JL (2010) Angiotensin II stimulates thick ascending limb superoxide production via protein kinase C(α)-dependent NADPH oxidase activation. J Biol Chem 285: 21323-21328 [CrossRef] [Google Scholar] [PubMed]